(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO30 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1551167 6480464 1, 2-Dimethylhydrazine results in decreased expression of FBXO30 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:1347238 6480464 Estradiol affects the expression of FBXO30 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551167 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBXO30 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551167 6480464 Tetrachlorodibenzodioxin affects the expression of FBXO30 mRNA CTD PMID:21570461 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FBXO30 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:1551167 6480464 n-butoxyethanol results in increased expression of FBXO30 mRNA CTD PMID:19812364 2-hydroxyethyl methacrylate increases expression ISO RGD:1347238 6480464 hydroxyethyl methacrylate results in increased expression of FBXO30 mRNA CTD PMID:30497689 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine decreases expression ISO RGD:1347238 6480464 2-amino-3-methylimidazo(4, 5-f)quinoline results in decreased expression of FBXO30 mRNA CTD PMID:26198647 4-hydroxynon-2-enal increases expression ISO RGD:1551167 6480464 4-hydroxy-2-nonenal results in increased expression of FBXO30 mRNA CTD PMID:19191707 aflatoxin B1 increases expression ISO RGD:1551167 6480464 Aflatoxin B1 results in increased expression of FBXO30 mRNA CTD PMID:19770486 arsenous acid increases expression ISO RGD:1347238 6480464 Arsenic Trioxide results in increased expression of FBXO30 mRNA CTD PMID:27829220 azathioprine increases expression ISO RGD:1347238 6480464 Azathioprine results in increased expression of FBXO30 mRNA CTD PMID:26198647 benzo[a]pyrene increases expression ISO RGD:1551167 6480464 Benzo(a)pyrene results in increased expression of FBXO30 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1347238 6480464 Benzo(a)pyrene results in increased methylation of FBXO30 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1347238 6480464 Benzo(a)pyrene results in increased expression of FBXO30 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1347238 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1551167 6480464 Diethylhexyl Phthalate results in increased expression of FBXO30 mRNA CTD PMID:21318169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FBXO30 mRNA CTD PMID:25181051 , PMID:30816183 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of FBXO30 mRNA CTD PMID:32479839 cadmium atom increases expression ISO RGD:1347238 6480464 Cadmium results in increased expression of FBXO30 mRNA CTD PMID:23369406 cadmium dichloride increases expression ISO RGD:1347238 6480464 Cadmium Chloride results in increased expression of FBXO30 mRNA CTD PMID:25596134 carbon nanotube decreases expression ISO RGD:1551167 6480464 Nanotubes, Carbon results in decreased expression of FBXO30 mRNA CTD PMID:25554681 chlorambucil decreases expression ISO RGD:1347238 6480464 Chlorambucil results in decreased expression of FBXO30 mRNA CTD PMID:26198647 chloroacetaldehyde decreases expression ISO RGD:1347238 6480464 chloroacetaldehyde results in decreased expression of FBXO30 mRNA CTD PMID:25596134 chlorpyrifos decreases expression ISO RGD:1551167 6480464 Chlorpyrifos results in decreased expression of FBXO30 mRNA CTD PMID:20350560 cidofovir anhydrous decreases expression ISO RGD:1347238 6480464 Cidofovir results in decreased expression of FBXO30 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1347238 6480464 Cisplatin results in decreased expression of FBXO30 mRNA CTD PMID:25596134 , PMID:27392435 clodronic acid decreases expression ISO RGD:1347238 6480464 Clodronic Acid results in decreased expression of FBXO30 mRNA CTD PMID:25596134 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of FBXO30 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1347238 6480464 cobaltous chloride results in increased expression of FBXO30 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1347238 6480464 [NSC 689534 binds to Copper] which results in increased expression of FBXO30 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1347238 6480464 [NSC 689534 binds to Copper] which results in increased expression of FBXO30 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1347238 6480464 Copper Sulfate results in increased expression of FBXO30 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1347238 6480464 Cyclosporine results in increased expression of FBXO30 mRNA CTD PMID:20106945 more ... diarsenic trioxide increases expression ISO RGD:1347238 6480464 Arsenic Trioxide results in increased expression of FBXO30 mRNA CTD PMID:27829220 diazinon increases expression ISO RGD:1347238 6480464 Diazinon results in increased expression of FBXO30 mRNA CTD PMID:26198647 diethylstilbestrol increases expression ISO RGD:1347238 6480464 Diethylstilbestrol results in increased expression of FBXO30 mRNA CTD PMID:26198647 dioxygen increases expression ISO RGD:1551167 6480464 Oxygen deficiency results in increased expression of FBXO30 mRNA CTD PMID:22629407 dioxygen decreases expression ISO RGD:1347238 6480464 Oxygen deficiency results in decreased expression of FBXO30 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:1551167 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FBXO30 mRNA] CTD PMID:22629407 doxorubicin increases expression ISO RGD:1347238 6480464 Doxorubicin results in increased expression of FBXO30 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of FBXO30 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:1347238 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FBXO30 protein CTD PMID:23301498 Ethyl acrylate increases expression ISO RGD:1347238 6480464 ethyl acrylate results in increased expression of FBXO30 mRNA CTD PMID:26198647 fenofibrate increases expression ISO RGD:1551167 6480464 Fenofibrate results in increased expression of FBXO30 mRNA CTD PMID:21318169 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of FBXO30 mRNA CTD PMID:25596134 fenofibrate multiple interactions ISO RGD:1551167 6480464 PPARA protein affects the reaction [Fenofibrate results in increased expression of FBXO30 mRNA] CTD PMID:21318169 flutamide increases expression EXP 6480464 Flutamide results in increased expression of FBXO30 mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:1347238 6480464 Formaldehyde results in decreased expression of FBXO30 mRNA CTD PMID:23649840 hydrogen peroxide affects expression ISO RGD:1347238 6480464 Hydrogen Peroxide affects the expression of FBXO30 mRNA CTD PMID:20044591 , PMID:23410634 ifosfamide decreases expression ISO RGD:1347238 6480464 Ifosfamide results in decreased expression of FBXO30 mRNA CTD PMID:25596134 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of FBXO30 mRNA CTD PMID:21396975 leflunomide increases expression ISO RGD:1347238 6480464 leflunomide results in increased expression of FBXO30 mRNA CTD PMID:28988120 menadione increases expression ISO RGD:1347238 6480464 Vitamin K 3 results in increased expression of FBXO30 mRNA CTD PMID:23410634 metformin increases expression EXP 6480464 Metformin results in increased expression of FBXO30 mRNA CTD PMID:25596134 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of FBXO30 mRNA CTD PMID:22110744 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO30 mRNA CTD PMID:25729387 para-Cresidine increases expression ISO RGD:1347238 6480464 cresidine results in increased expression of FBXO30 mRNA CTD PMID:26198647 paracetamol affects expression ISO RGD:1551167 6480464 Acetaminophen affects the expression of FBXO30 mRNA CTD PMID:17562736 paracetamol affects expression ISO RGD:1347238 6480464 Acetaminophen affects the expression of FBXO30 mRNA CTD PMID:21420995 pentachlorophenol increases expression ISO RGD:1551167 6480464 Pentachlorophenol results in increased expression of FBXO30 mRNA CTD PMID:23892564 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of FBXO30 mRNA CTD PMID:19162173 , PMID:21318169 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of FBXO30 mRNA CTD PMID:20345932 phorone affects expression EXP 6480464 phorone affects the expression of FBXO30 mRNA CTD PMID:18198479 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of FBXO30 mRNA CTD PMID:12832660 pirinixic acid increases expression ISO RGD:1551167 6480464 pirinixic acid results in increased expression of FBXO30 mRNA CTD PMID:18301758 , PMID:21318169 pirinixic acid multiple interactions ISO RGD:1551167 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of FBXO30 mRNA] CTD PMID:21318169 propiconazole increases expression ISO RGD:1551167 6480464 propiconazole results in increased expression of FBXO30 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1347238 6480464 Quercetin results in decreased expression of FBXO30 mRNA CTD PMID:21632981 resorcinol increases expression ISO RGD:1347238 6480464 resorcinol results in increased expression of FBXO30 mRNA CTD PMID:26198647 silver atom affects expression ISO RGD:1551167 6480464 Silver affects the expression of FBXO30 mRNA CTD PMID:27131904 silver atom increases expression ISO RGD:1347238 6480464 Silver results in increased expression of FBXO30 mRNA CTD PMID:26014281 silver(0) affects expression ISO RGD:1551167 6480464 Silver affects the expression of FBXO30 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1347238 6480464 Silver results in increased expression of FBXO30 mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:1551167 6480464 sodium arsenite results in increased expression of FBXO30 mRNA CTD PMID:25270620 Soman increases expression EXP 6480464 Soman results in increased expression of FBXO30 mRNA CTD PMID:19281266 tert-butyl hydroperoxide increases expression ISO RGD:1347238 6480464 tert-Butylhydroperoxide results in increased expression of FBXO30 mRNA CTD PMID:23410634 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO30 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1551167 6480464 Carbon Tetrachloride results in increased expression of FBXO30 mRNA CTD PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FBXO30 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FBXO30 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:1551167 6480464 titanium dioxide results in decreased expression of FBXO30 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO30 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FBXO30 mRNA CTD PMID:25729387 Tributyltin oxide increases expression ISO RGD:1347238 6480464 bis(tri-n-butyltin)oxide results in increased expression of FBXO30 mRNA CTD PMID:26198647 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of FBXO30 mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:1551167 6480464 troglitazone results in decreased expression of FBXO30 mRNA CTD PMID:28973697 urethane increases expression ISO RGD:1347238 6480464 Urethane results in increased expression of FBXO30 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1347238 6480464 Valproic Acid results in decreased expression of FBXO30 mRNA CTD PMID:23179753 valproic acid increases expression ISO RGD:1347238 6480464 Valproic Acid results in increased expression of FBXO30 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1347238 6480464 Valproic Acid affects the expression of FBXO30 mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of FBXO30 mRNA CTD PMID:20566332 , PMID:23869203 zinc atom multiple interactions ISO RGD:1347238 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO30 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1347238 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO30 mRNA CTD PMID:18593933 
Gene Ontology Annotations
